Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;30(10):8589-8597.
doi: 10.1007/s00520-022-07045-y. Epub 2022 May 5.

Risk factors associated with venous thromboembolism in breast cancer: a narrative review

Zayd Adnan Razouki  1 , Nadeen T Ali  2   3 , Vinh Q Nguyen  4 , Carmen P Escalante  4
Affiliations
Review

Risk factors associated with venous thromboembolism in breast cancer: a narrative review

Zayd Adnan Razouki et al. Support Care Cancer. 2022 Oct.

Abstract

Purpose: To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the most relevant risk factors for VTE in these patients.

Methods: We searched Ovid Embase and Ovid MEDLINE, from inception to March 26, 2021, to identify all articles that focused on breast cancer and multiple thromboembolic diseases. We also searched the references section of relevant articles to identify studies. We did not include case reports or case series with small sample size, N < 20.

Results: VTE in patients with breast cancer was strongly associated with patient-, tumor-, and non-tumor-related risk factors, such as age, disease stage, central catheter placement, and chemotherapy and tamoxifen use, especially within 2 years of breast cancer diagnosis. CDK inhibitors are emerging factors that may also increase the risk of VTE.

Conclusions: The risk of VTE in patients with breast cancer depends on various patient-, tumor-, and non-tumor-related risk factors. Identifying these risk factors during breast cancer diagnosis and treatment is essential in developing a practical dynamic predictive tool that can help individualize strategies to prevent VTE.

Keywords: Breast cancer; Deep vein thrombosis; Pulmonary embolism; Risk factors.

PubMed Disclaimer

References

    1. Walker AJ, Card TR, West J, Crooks C, Grainge MJ (2013) Incidence of venous thromboembolism in patients with cancer–a cohort study using linked United Kingdom databases. Eur J Cancer 49(6):1404–1413 - PubMed
    1. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH (2006) Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24(3):484–490 - PubMed
    1. Paneesha S, McManus A, Arya R, Scriven N, Farren T, Nokes T et al (2010) Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics. Thromb Haemost 103(02):338–343 - PubMed
    1. Khan UT, Walker AJ, Baig S, Card TR, Kirwan CC, Grainge MJ (2017) Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis. BMC Cancer 17(1):1–13
    1. Rebouças D, Costa M, Thuler L, Garces A, Aquino L, Bines J (2016) Breast cancer-associated venous thromboembolism: a case–control study. The Breast 28:84–88 - PubMed

LinkOut - more resources